IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2
Go back to IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2| Merck & Co. (NYSE: MRK) | Delayed: 152.20 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $152.20 | 52 Week High | $65.46 | |||
| Open | $152.20 | 52 Week Low | $47.97 | |||
| Day High | $152.20 | P/E | 103.54 | |||
| Day Low | $152.20 | EPS | $1.47 | |||
| Volume | 33,744 | |||||
